1	Una	Una		C0205447_1	calificador_1	0-3	148_QUEST_clinical_caseMIR	SENT1	-	-
2	enferma	enfermo	NCFS000	-	-	4-11	148_QUEST_clinical_caseMIR	SENT1	-	-
3	de	de	SPS00	C0332285	atributo	12-14	148_QUEST_clinical_caseMIR	SENT1	-	-
4	60	60		-	-	15-17	148_QUEST_clinical_caseMIR	SENT1	-	-
5	años	año	NCMP000	C0439234	calificador	18-22	148_QUEST_clinical_caseMIR	SENT1	-	-
6	diagnosticada	diagnosticar	VMP00SF	-	-	23-36	148_QUEST_clinical_caseMIR	SENT1	-	-
7	de	de	SPS00	C0332285	atributo	37-39	148_QUEST_clinical_caseMIR	SENT1	-	-
8	broncopatía	broncopatía	NCFS000	-	-	40-51	148_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
9	crónica	crónico	AQ0FS0	C0205191	calificador	52-59	148_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
10	,	,	Fc	-	-	59-60	148_QUEST_clinical_caseMIR	SENT1	-	-
11	diabetes	diabetes	NCFN000	C0011849_1	trastorno_1	61-69	148_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
12	mellitus	mellitus	AQ0CN0	C0011849_2	trastorno_2	70-78	148_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-
13	,	,	Fc	-	-	78-79	148_QUEST_clinical_caseMIR	SENT1	-	-
14	hipertensión	hipertensión	NCFS000	C0020538_1	trastorno_1	80-92	148_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
15	arterial	arterial	NC00SC0	C0020538_2	trastorno_2	93-101	148_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
16	y	y	CC	C1706368	calificador	102-103	148_QUEST_clinical_caseMIR	SENT1	-	-
17	tratada	tratar	VMP00SF	-	-	104-111	148_QUEST_clinical_caseMIR	SENT1	-	-
18	desde	desde	SPS00	-	-	112-117	148_QUEST_clinical_caseMIR	SENT1	-	-
19	hace	hacer	VMIP3S0	-	-	118-122	148_QUEST_clinical_caseMIR	SENT1	-	-
20	4	4		-	-	123-124	148_QUEST_clinical_caseMIR	SENT1	-	-
21	meses	mes	NCMP000	C0439231	calificador	125-130	148_QUEST_clinical_caseMIR	SENT1	-	-
22	con	con	SPS00	C0332287	atributo	131-134	148_QUEST_clinical_caseMIR	SENT1	-	-
23	Omeprazol	omeprazol	NC00SC0	C0028978	sustancia	135-144	148_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
24	,	,	Fc	-	-	144-145	148_QUEST_clinical_caseMIR	SENT1	-	-
25	Metformina	metformina	NC00SC0	C0025598	producto#sustancia	146-156	148_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
26	,	,	Fc	-	-	156-157	148_QUEST_clinical_caseMIR	SENT1	-	-
27	Salbutamol	salbutamol	NC00SC0	C0001927	producto	158-168	148_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
28	,	,	Fc	-	-	168-169	148_QUEST_clinical_caseMIR	SENT1	-	-
29	Bromuro	bromuro	NCMS000	C0700580_1	producto#sustancia_1	170-177	148_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
30	de	de	SPS00	C0700580_2	producto#sustancia_2	178-180	148_QUEST_clinical_caseMIR	SENT1	-	-
31	Ipratropio	ipratropio	NC00SC0	C0700580_3	producto#sustancia_3	181-191	148_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
32	y	y	CC	C1706368	calificador	192-193	148_QUEST_clinical_caseMIR	SENT1	-	-
33	Enalapril	enalapril	NC00SC0	C0014025	sustancia	194-203	148_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
34	20	20	Z	-	-	204-206	148_QUEST_clinical_caseMIR	SENT1	-	-
35	mg	mg	NCMN000	-	-	207-209	148_QUEST_clinical_caseMIR	SENT1	-	-
36	+	+	Fz	-	-	210-211	148_QUEST_clinical_caseMIR	SENT1	-	-
37	Hidroclorotiazida	hidroclorotiazida	NCMS000	C0020261	producto#sustancia	212-229	148_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
38	25	25	Z	-	-	230-232	148_QUEST_clinical_caseMIR	SENT1	-	-
39	mg	mg	NCMN000	-	-	233-235	148_QUEST_clinical_caseMIR	SENT1	-	-
40	.	.	Fp	-	-	235-236	148_QUEST_clinical_caseMIR	SENT1	-	-

1	Acude	acudir	VMIP3S0	-	-	237-242	148_QUEST_clinical_caseMIR	SENT2	-	-
2	a	a	SPS00	-	-	243-244	148_QUEST_clinical_caseMIR	SENT2	-	-
3	su	su	DP3CS0	-	-	245-247	148_QUEST_clinical_caseMIR	SENT2	-	-
4	médica	médico	AQ0FS0	C0205476#C0031831	calificador#ocupación	248-254	148_QUEST_clinical_caseMIR	SENT2	-	-
5	por	por	SPS00	C0678226	atributo	255-258	148_QUEST_clinical_caseMIR	SENT2	-	-
6	cansancio	cansancio	NCMS000	C0015672#C0475255	hallazgo#calificador	259-268	148_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
7	,	,	Fc	-	-	268-269	148_QUEST_clinical_caseMIR	SENT2	-	-
8	disminución	disminución	NCFS000	C0333668#C0547047	anomalía_morfológica#calificador	270-281	148_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
9	de	de	SPS00	C0332285	atributo	282-284	148_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
10	apetito	apetito	NCMS000	C0003618	función	285-292	148_QUEST_clinical_caseMIR	SENT2	I-Calificador	-
11	,	,	Fc	-	-	292-293	148_QUEST_clinical_caseMIR	SENT2	-	-
12	con	con	SPS00	C0332287	atributo	294-297	148_QUEST_clinical_caseMIR	SENT2	-	-
13	ligera	ligero	AQ0FS0	-	-	298-304	148_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
14	disnea	disnea	NCFS000	C0013404#C0553668	hallazgo	305-311	148_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
15	y	y	CC	C1706368	calificador	312-313	148_QUEST_clinical_caseMIR	SENT2	-	-
16	tos	tos	NCFS000	C0010200_1	entidad_observable#hallazgo_1	314-317	148_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
17	ocasional	ocasional	AQ0CS0	C0521114	calificador	318-327	148_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
18	,	,	Fc	-	-	327-328	148_QUEST_clinical_caseMIR	SENT2	-	-
19	deposiciones	deposición	NCFP000	-	-	329-341	148_QUEST_clinical_caseMIR	SENT2	-	-
20	variables	variable	AQ0CP0	C0439828#C0392747	calificador	342-351	148_QUEST_clinical_caseMIR	SENT2	-	-
21	,	,	Fc	-	-	351-352	148_QUEST_clinical_caseMIR	SENT2	-	-
22	a	a	SPS00	-	-	353-354	148_QUEST_clinical_caseMIR	SENT2	-	-
23	veces	vez	NCFP000	-	-	355-360	148_QUEST_clinical_caseMIR	SENT2	-	-
24	blandas	blando	AQ0FP0	C0205358	calificador	361-368	148_QUEST_clinical_caseMIR	SENT2	-	-
25	y	y	CC	C1706368	calificador	369-370	148_QUEST_clinical_caseMIR	SENT2	-	-
26	sin	sin	SPS00	C0332288	atributo	371-374	148_QUEST_clinical_caseMIR	SENT2	-	-
27	síntomas	síntoma	NCMP000	C0426359_1	hallazgo_1	375-383	148_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	Negacion
28	urinarios	urinario	NCMP000	C0426359_2	hallazgo_2	384-393	148_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
29	.	.	Fp	-	-	393-394	148_QUEST_clinical_caseMIR	SENT2	-	-

1	Unos	uno	DI0MP0	C0205447	calificador	395-399	148_QUEST_clinical_caseMIR	SENT3	-	-
2	análisis	análisis	NCMN000	C0002778	calificador	400-408	148_QUEST_clinical_caseMIR	SENT3	-	-
3	muestran	mostrar	VMIP3P0	-	-	409-417	148_QUEST_clinical_caseMIR	SENT3	-	-
4	leucocitos	leucocito	NCMP000	C0023516	célula	418-428	148_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-
5	10.000/mm3	10.000/mm3		-	-	429-439	148_QUEST_clinical_caseMIR	SENT3	-	-
6	,	,	Fc	-	-	439-440	148_QUEST_clinical_caseMIR	SENT3	-	-
7	Hto	hematócrito	NC00YL0	-	-	441-444	148_QUEST_clinical_caseMIR	SENT3	-	-
8	35	35	Z	-	-	445-447	148_QUEST_clinical_caseMIR	SENT3	-	-
9	%	%	Ft	-	-	447-448	148_QUEST_clinical_caseMIR	SENT3	-	-
10	,	,	Fc	-	-	448-449	148_QUEST_clinical_caseMIR	SENT3	-	-
11	VCM	vcm	NC00SC0	C0524587	entidad_observable	450-453	148_QUEST_clinical_caseMIR	SENT3	-	-
12	80	80		-	-	454-456	148_QUEST_clinical_caseMIR	SENT3	-	-
13	,	,	Fc	-	-	456-457	148_QUEST_clinical_caseMIR	SENT3	-	-
14	Glucosa	glucosa	NCFS000	C0017725	sustancia#producto	458-465	148_QUEST_clinical_caseMIR	SENT3	-	-
15	150	150	Z	-	-	466-469	148_QUEST_clinical_caseMIR	SENT3	-	-
16	mg	mg	NCMN000	-	-	470-472	148_QUEST_clinical_caseMIR	SENT3	-	-
17	/	/	Fh	-	-	472-473	148_QUEST_clinical_caseMIR	SENT3	-	-
18	dl	decilitro	NCMN000	C0439241	calificador	473-475	148_QUEST_clinical_caseMIR	SENT3	-	-
19	,	,	Fc	-	-	475-476	148_QUEST_clinical_caseMIR	SENT3	-	-
20	Urea	urea	NCFS000	C0041942	sustancia	477-481	148_QUEST_clinical_caseMIR	SENT3	-	-
21	80	80	Z	-	-	482-484	148_QUEST_clinical_caseMIR	SENT3	-	-
22	mg	mg	NCMN000	-	-	485-487	148_QUEST_clinical_caseMIR	SENT3	-	-
23	/	/	Fh	-	-	487-488	148_QUEST_clinical_caseMIR	SENT3	-	-
24	dl	decilitro	NCMN000	C0439241	calificador	488-490	148_QUEST_clinical_caseMIR	SENT3	-	-
25	,	,	Fc	-	-	490-491	148_QUEST_clinical_caseMIR	SENT3	-	-
26	Creatinina	creatinina	NC00SC0	C0010294	sustancia	492-502	148_QUEST_clinical_caseMIR	SENT3	-	-
27	1,6	1.6	Z	-	-	503-506	148_QUEST_clinical_caseMIR	SENT3	-	-
28	mg	mg	NCMN000	-	-	507-509	148_QUEST_clinical_caseMIR	SENT3	-	-
29	/	/	Fh	-	-	509-510	148_QUEST_clinical_caseMIR	SENT3	-	-
30	dl	decilitro	NCMN000	C0439241	calificador	510-512	148_QUEST_clinical_caseMIR	SENT3	-	-
31	,	,	Fc	-	-	512-513	148_QUEST_clinical_caseMIR	SENT3	-	-
32	Sodio	sodio	NCMS000	C3536896#C0037473	producto#sustancia	514-519	148_QUEST_clinical_caseMIR	SENT3	-	-
33	133	133		-	-	520-523	148_QUEST_clinical_caseMIR	SENT3	-	-
34	meq	miliequivalente_(10-3_mol_dividido_por_la_valencia)	NC00YL0	-	-	524-527	148_QUEST_clinical_caseMIR	SENT3	-	-
35	/	/	Fh	-	-	527-528	148_QUEST_clinical_caseMIR	SENT3	-	-
36	l	l	NCFS000	-	-	528-529	148_QUEST_clinical_caseMIR	SENT3	-	-
37	y	y	CC	C1706368	calificador	530-531	148_QUEST_clinical_caseMIR	SENT3	-	-
38	Potasio	potasio	NCMS000	C0032821	sustancia#producto	532-539	148_QUEST_clinical_caseMIR	SENT3	-	-
39	2,9	2,9		-	-	540-543	148_QUEST_clinical_caseMIR	SENT3	-	-
40	mEq	miliequivalente_(10-3_mol_dividido_por_la_valencia)	NC00YL0	-	-	544-547	148_QUEST_clinical_caseMIR	SENT3	-	-
41	/	/	Fh	-	-	547-548	148_QUEST_clinical_caseMIR	SENT3	-	-
42	l	l	NCFS000	-	-	548-549	148_QUEST_clinical_caseMIR	SENT3	-	-
43	.	.	Fp	-	-	549-550	148_QUEST_clinical_caseMIR	SENT3	-	-

1	¿	¿	Fia	-	-	551-552	148_QUEST_clinical_caseMIR	SENT4	-	-
2	Cuál	cuál	PT0CS000	-	-	552-556	148_QUEST_clinical_caseMIR	SENT4	-	-
3	es	ser	VSIP3S0	-	-	557-559	148_QUEST_clinical_caseMIR	SENT4	-	-
4	la	el	DA0FS0	-	-	560-562	148_QUEST_clinical_caseMIR	SENT4	-	-
5	causa	causa	NCFS000	-	-	563-568	148_QUEST_clinical_caseMIR	SENT4	-	-
6	más	más	RG	C0205172	calificador	569-572	148_QUEST_clinical_caseMIR	SENT4	-	-
7	probable	probable	AQ0CS0	C0332148	calificador	573-581	148_QUEST_clinical_caseMIR	SENT4	-	-
8	de	de	SPS00	C0332285	atributo	582-584	148_QUEST_clinical_caseMIR	SENT4	-	-
9	la	el	DA0FS0	-	-	585-587	148_QUEST_clinical_caseMIR	SENT4	-	-
10	hipopotasemia	hipopotasemia	NCFS000	C0020621#C1971021#C0032827	trastorno	588-601	148_QUEST_clinical_caseMIR	SENT4	B-Grp_Enfermedad	Especulacion
11	?	?	Fit	-	-	601-602	148_QUEST_clinical_caseMIR	SENT4	-	-
12	:	:	Fd	-	-	602-603	148_QUEST_clinical_caseMIR	SENT4	-	-
13	.	.	Fp	-	-	603-604	148_QUEST_clinical_caseMIR	SENT4	-	-

